Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Bioorganic & Medicinal Chemistry Letters
|
August 6, 2008
8-Biarylchromen-4-one inhibitors of the DNA-dependent protein kinase (DNA-PK)
Marine Desage-El Murr, Celine Cano, Bernard T Golding, et al.
Molecular Cancer Therapeutics
|
October 8, 2009
Improved ATM kinase inhibitor KU-60019 radiosensitizes glioma cells, compromises insulin, AKT and ERK prosurvival signaling, and inhibits migration and invasion
Sarah E Golding, Elizabeth Rosenberg, Nicholas Valerie, et al.
Bioconjugate Chemistry
|
May 6, 2014
Bridging disulfides for stable and defined antibody drug conjugates
George Badescu, Penny Bryant, Matthew Bird, et al.
Journal of Medicinal Chemistry
|
July 17, 2013
1-substituted (Dibenzo[b,d]thiophen-4-yl)-2-morpholino-4H-chromen-4-ones endowed with dual DNA-PK/PI3-K inhibitory activity
Céline Cano, Kappusamy Saravanan, Chris Bailey, et al.
Frontiers in Pharmacology
|
July 5, 2022
Incorporation of Hydrophilic Macrocycles Into Drug-Linker Reagents Produces Antibody-Drug Conjugates With Enhanced <i>in vivo</i> Performance
Nick Evans, Ruslan Grygorash, Paul Williams, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
December 17, 2013
On and off-target effects of telomere uncapping G-quadruplex selective ligands based on pentacyclic acridinium salts
Sara Iachettini, Malcolm Fg Stevens, Mark Frigerio, et al.
Journal of Medicinal Chemistry
|
November 18, 2010
DNA-dependent protein kinase (DNA-PK) inhibitors. Synthesis and biological activity of quinolin-4-one and pyridopyrimidin-4-one surrogates for the chromen-4-one chemotype
Céline Cano, Olivier R Barbeau, Christine Bailey, et al.
Molecular Pharmaceutics
|
April 21, 2015
In Vitro and In Vivo Evaluation of Cysteine Rebridged Trastuzumab-MMAE Antibody Drug Conjugates with Defined Drug-to-Antibody Ratios
Penny Bryant, Martin Pabst, George Badescu, et al.
Journal of Medicinal Chemistry
|
March 21, 2007
Pyranone, thiopyranone, and pyridone inhibitors of phosphatidylinositol 3-kinase related kinases. Structure-activity relationships for DNA-dependent protein kinase inhibition, and identification of the first potent and selective inhibitor of the ataxia telangiectasia mutated kinase
Jonathan J Hollick, Laurent J M Rigoreau, Celine Cano-Soumillac, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
March 5, 2017
Modulation of drug-linker design to enhance in vivo potency of homogeneous antibody-drug conjugates
Martin Pabst, William McDowell, Anaïs Manin, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Bioorganic & Medicinal Chemistry Letters
|
August 6, 2008
8-Biarylchromen-4-one inhibitors of the DNA-dependent protein kinase (DNA-PK)
Marine Desage-El Murr, Celine Cano, Bernard T Golding, et al.
Molecular Cancer Therapeutics
|
October 8, 2009
Improved ATM kinase inhibitor KU-60019 radiosensitizes glioma cells, compromises insulin, AKT and ERK prosurvival signaling, and inhibits migration and invasion
Sarah E Golding, Elizabeth Rosenberg, Nicholas Valerie, et al.
Bioconjugate Chemistry
|
May 6, 2014
Bridging disulfides for stable and defined antibody drug conjugates
George Badescu, Penny Bryant, Matthew Bird, et al.
Journal of Medicinal Chemistry
|
July 17, 2013
1-substituted (Dibenzo[b,d]thiophen-4-yl)-2-morpholino-4H-chromen-4-ones endowed with dual DNA-PK/PI3-K inhibitory activity
Céline Cano, Kappusamy Saravanan, Chris Bailey, et al.
Frontiers in Pharmacology
|
July 5, 2022
Incorporation of Hydrophilic Macrocycles Into Drug-Linker Reagents Produces Antibody-Drug Conjugates With Enhanced <i>in vivo</i> Performance
Nick Evans, Ruslan Grygorash, Paul Williams, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
December 17, 2013
On and off-target effects of telomere uncapping G-quadruplex selective ligands based on pentacyclic acridinium salts
Sara Iachettini, Malcolm Fg Stevens, Mark Frigerio, et al.
Journal of Medicinal Chemistry
|
November 18, 2010
DNA-dependent protein kinase (DNA-PK) inhibitors. Synthesis and biological activity of quinolin-4-one and pyridopyrimidin-4-one surrogates for the chromen-4-one chemotype
Céline Cano, Olivier R Barbeau, Christine Bailey, et al.
Molecular Pharmaceutics
|
April 21, 2015
In Vitro and In Vivo Evaluation of Cysteine Rebridged Trastuzumab-MMAE Antibody Drug Conjugates with Defined Drug-to-Antibody Ratios
Penny Bryant, Martin Pabst, George Badescu, et al.
Journal of Medicinal Chemistry
|
March 21, 2007
Pyranone, thiopyranone, and pyridone inhibitors of phosphatidylinositol 3-kinase related kinases. Structure-activity relationships for DNA-dependent protein kinase inhibition, and identification of the first potent and selective inhibitor of the ataxia telangiectasia mutated kinase
Jonathan J Hollick, Laurent J M Rigoreau, Celine Cano-Soumillac, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
March 5, 2017
Modulation of drug-linker design to enhance in vivo potency of homogeneous antibody-drug conjugates
Martin Pabst, William McDowell, Anaïs Manin, et al.
Page
of 2